poisar

Stocks · News reference

Benitec Biopharma Reports First Quarter Fiscal 2027 Financial Results and Provides Operational Update

Fiscal.ai

Benitec Biopharma announced its financial results for the fiscal quarter ended September 30, 2026, and reported positive interim clinical data for its BB-301 program.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Benitec Biopharma Inc. (BNTC)

    Filed: 2026-11-13 AccNo: 0001193125-26-459339 Size: 378 KB Item 2.02: Results of Operations and Financial Condition Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits